Skip to content

A Pilot Study of the InterCushion Disc Nucleus Prosthesis (DNP) in Patients Receiving Discectomy

A Pilot Clinical Study to Assess the Safety and Effectiveness of the InterCushion Disc Nucleus Prosthesis in Patients Receiving Discectomy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01652053
Enrollment
100
Registered
2012-07-27
Start date
2012-01-31
Completion date
2018-06-30
Last updated
2016-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disk, Herniated

Keywords

InterCushion

Brief summary

The primary endpoints of the investigation will include assessment of the maintenance of disc height demonstrated by radiographic evidence based on plain radiographs and MRI and relief of pain as measured by Visual Analog Scale (VAS) at six months post-surgery. It is anticipated that outcomes with the InterCushion Disc Nucleus Prosthesis (DNP) will be comparable to or better than the historical published results for discectomy alone.

Detailed description

All patients will be followed for at least 24 months once enrolled in the study. Clinical evaluations will be conducted before surgery (baseline), intraoperative, 2 week (± 1 week), 6 week (± 1 week), 3 months (± 2 weeks), 6 months (± 1 month), 12 months (± 2 months) and 24 months (± 2 months).

Interventions

DEVICEDisc Nucleus Replacement (InterCushion DNP)

The device is intended for spinal arthroplasty in skeletally mature patients with leg pain due to a herniated disc with or without back pain, who are having a discectomy at one level from L2 -S1. These patients should have no spondylolisthesis at the involved level.

Sponsors

Vertebral Technologies, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patient has signed and dated a study specific informed consent form approved by the reviewing Institutional Review Board or Ethics Committee. * Patient is 21 to 60 years of age. * Patient is skeletally mature * Patient requires a discectomy of one level from L2-S1. * Patient has less than 50% loss of disc height at the affected level. * Patient has persistent pain (predominantly leg pain, although some back pain that occurred at the same time as the leg pain and is believed to be associated with the disc herniation will not disqualify the patient from participating in this study) and symptoms despite a minimum of six weeks of non-operative treatment. * Patient X-ray, CT or MR evidence of a herniated disc at the affected level. * Patient has a minimum leg pain score of 6 cm on a 10 cm (i.e. 60 mm on a 100 mm) point visual analog scale (VAS). * Patient has a minimum Oswestry Disability Index score of 40% (based upon a 100% scale). * Patient is physically and mentally willing and able to comply with the postoperative scheduled clinical and radiographic evaluations and rehabilitation.

Exclusion criteria

* Patient has had any previous surgery at the affected levels. * Patient has had any attempt at spinal fusion, at any lumbar levels. * Patient has motion of \< 3 degrees on pre-operative lateral flexion/extension radiographs * Patient has a BMI * Patient has severe osteoporosis of the spine. * Patient has previously undergone chemotherapy, immunosuppressive therapy or radiation to the local area. * Patient has active local or systemic infection. * Patient has any known active malignancy. * Patient has rheumatoid arthritis or systemic lupus erythematosus, or other chronic, inflammatory autoimmune disorder. * Patient has ankylosing spondylitis or other spondyloarthropathy. * Patient has spondylolisthesis. * Patient is pregnant or plans to become pregnant during the course of the study. * Patient has other concurrent physical or mental conditions that are likely to affect their outcome. * Patient has congenital stenosis * Patient is diabetic. * The patient has osteoporosis or severe osteopenia as determined by the Investigator. Females over 40 with bone density score less than -1. A clinical SCORE calculator may also be utilized for females over 40 years of age. * Patient has significant facet disease.

Design outcomes

Primary

MeasureTime frameDescription
Neurologic deficits6 monthsNo new permanent neurological deficit or worsening of an existing permanent neurological deficit
Decrease in ODI6 monthsImprovement in the Oswestry Disability Index (ODI) score i.e. decrease of 15% or better ODI.
Decrease in VAS6 monthsImprovement in leg pain evidenced by decrease in pain score of at least 2 cm (i.e. 20 mm) on the visual analog scale (VAS)
Maintenance of post-operative disc height6 monthsDisc at the treated level is collapsed by ≤ 15% when compared to an adjacent health level.
Mobility of treated segment6 monthsMotion of ≥ 3 degrees on lateral flexion/extension radiographs

Secondary

MeasureTime frameDescription
Neurological deficits12 and 24 monthsNo new permanent neurological deficit or worsening of an existing permanent neurological deficit
Maintenance or decrease in ODI12 and 24 monthsMaintenance of improvement or further improvement in the Oswestry Disability Index (ODI) score measured at six months i.e. decrease of 15% or better ODI.
Maintenance or decrease in VAS12 and 24 monthsMaintenance of improvement or further improvement in leg pain evidenced by decrease in pain score on the visual analog scale (VAS)
Maintenance of post-operative disc height.12 and 24 monthsDisc at the treated level is collapsed by ≤ 15% when compared to an adjacent health level.
Mobility of treated segment12 and 24 monthsMotion of ≥ 3 degrees on lateral flexion/extension radiographs

Other

MeasureTime frameDescription
Failures6, 12 and 24 monthsRevision: is a procedure that adjusts or in any way modifies or removes part of the original implant configuration, with or without replacement of a component. Removal: is a procedure where the entire original system configuration is removed with or without replacement. Supplemental fixation: a procedure in which additional instrumentation not under study is implanted.

Countries

Canada

Contacts

Primary ContactLaurie E Lynch, PhD
laurie.lynch@visi.com952-221-2468
Backup ContactFelt Jeff, MD
jfelt@vti-spine.com612-708-4838

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026